alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
PATRICK J TOOMEY I ENN ·yo VANIA

Ms. Ashley Armstrong U.S. Department of Energy 

# !lnitcd**~totes ~mate**  WASHINGTON, DC 20510 May 22, 2015

Office of Energy Efficiency and Renewable Energy Building Technologies Program , EE

- SB 1000 Independence Avenue, S.W. Washington, D.C. 20585 Dear Ms. Armstrong, COMM11"Tf£.$: FINANCE BANKING, HOUSING, ANO URBAN AFFAIRS BUDGET

I write to you regarding the Department of Energy's recent p roposal to modify current test procedures for residential furnaces and boilers, Docket No. EERE-2012-BT-TP

- 0024
. I have heard from multiple constituents who have concerns that the original comment period is not long enough for necessary review. This proposal would have a significant impact on manufacturers across the country , including my home state of Pennsylvania, and these individuals must have the opportunity to contribute to the rulemaking process. As such, I urge you to extend the comment period for this proposed rule by 45 days to allow adequa t e time for stakeholders to we i gh in. Although energy effic iency is of utmost conc ern , I believe the agency should utilize all re levant input w hen dev el oping new energy standards. Moreover , I ask that you provide stakeholders and interested part i es with all appropriate test information so that they may evaluate the proposed rule objectively. Thank you for your consideration
. Please do not hesitate to contact Brett Doyle, of my staff , at brett doyle@toomey.senate.gov or at (202) 224-4254. Sincerely,
Exhibit 99.2









Report of Independent Registered Public Accounting Firm

To the Management of Protective Life Insurance Company and The Bank of New York, as Indenture Trustee of Protective
Life Secured Trust 2004-47, (collectively the "Management")
and Wilmington Trust Company, as Trustee of Protective Life Secured Trust 2004-47 (the "Trust"):

We have examined Management's assertion, included in the accompanying "Management Assertion Regarding the Collection and Distribution of Trust Money by The Bank of New York (Indenture Trustee)," that the collection of payments on the funding agreements and distribution of payments to the noteholders has occurred as required by Section 5.02 of the Indenture agreement dated November 7, 2003 between the Trust and the Indenture Trustee during the year ended December 31, 2004.  Management is responsible for the assertion.  Our responsibility is to express an opinion on the assertion based on our examination.

Our examination was conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) and, accordingly, included examining, on a test basis, evidence supporting management's assertion and performing such other procedures as we considered necessary in the circumstances.  We believe that our examination provides a reasonable basis for our opinion.

In our opinion, Management's assertion referred to above is fairly stated, in all material respects, based on the criteria defined in the accompanying "Management Assertion Regarding the Collection and Distribution of Trust Money by The Bank of New York (Indenture Trustee)."



PricewaterhouseCoopers LLP

Birmingham, AlabamaMarch 30, 2005











Management Assertion Regarding the Collection and Distribution of Trust
Money by The Bank of New York (Indenture Trustee)





Management of the Trust asserts that it has collected payments on the funding agreements and distributed payments to the noteholders as required by Section 5.02 of the Indenture agreement dated November 7, 2003 between the Trust and the Indenture Trustee for the year ended December 31, 2004.  This assertion is based on the following criteria:

1. The payments made by Protective Life on the funding agreements that secured the Notes, for the year ended December 31, 2004, are included in Protective Life's Secured Trusts P & I Payments: 1/1/04 through 12/31/04 (P & I Payments report).
2. The payments made by Protective Life on the funding agreements that secured the Notes, for the year ended December 31, 2004, are included in the Indenture Trustee's History of Transactions List.
3. The amounts due on the Notes are reported as a component of the charges from Cede & Co., the nominee of the Depository Trust Company, on the Indenture Trustee's Payment Obligation Report System (PORS Report).
4. Charges from Cede & Co. are included in the Indenture Trustee's screen prints titled The Depository Trust Company Activity History Details, which represent the charge confirmations to Cede & Co., the nominee of the Depository Trust Company.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
Financial Data Schedule for Olympus Communications LP for the three
months ended March 31, 1997.  Information is only included for Olympus
Communications LP(a registrant) and does not include information for Olympus
Capital Corp., which has no operations.
</LEGEND>
<CIK> 0000861255
<NAME> OLYMPUS COMMUNICATIONS LP
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                          13,512
<SECURITIES>                                         0
<RECEIVABLES>                                    9,528<F1>
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         229,140<F2>
<DEPRECIATION>                                       0<F2>
<TOTAL-ASSETS>                                 627,392
<CURRENT-LIABILITIES>                                0
<BONDS>                                        559,573
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                    (87,917)
<TOTAL-LIABILITY-AND-EQUITY>                   627,392
<SALES>                                              0
<TOTAL-REVENUES>                                41,411
<CGS>                                                0
<TOTAL-COSTS>                                   33,676
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,084
<INCOME-PRETAX>                                (5,393)
<INCOME-TAX>                                      (75)
<INCOME-CONTINUING>                            (5,318)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,318)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
<FN>
<F1>Receivables are net of Allowance
<F2>PP&E is net of Depreciation
</FN>
        

</TABLE>
Exhibit 10.1

 






























































































































































 

AMENDMENT to TECHNICAL SERVICES AGREEMENT

 

This AMENDMENT to TECHNICAL SERVICES AGREEMENT (this “Amendment”), dated as of October 27, 2011, is between United Therapeutics Corporation, located at 1040 Spring St., Silver Spring, MD 20910, (“United Therapeutics”) and Kurzweil Technologies, Inc., (“KTI”).  Party shall mean United Therapeutics or KTI as the context dictates, and “Parties” shall mean United Therapeutics and KTI.

 

WHEREAS, United Therapeutics and KTI are parties to that certain Technical Services Agreement dated May 15, 2007 (the “TSA”);

 

WHEREAS, United Therapeutics and KTI wish to amend the TSA to align with changed circumstances.

 

NOW, THEREFORE, in consideration of the terms and conditions specified herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows:

 

1.               AMENDMENTS.  The TSA is hereby amended, with effect from January 1, 2012, as follows:

 

1.1.           In Section 2(a), each instance of the number “$12,000” is replaced with “$6,000.”

 

1.2.           In Section 2(a), the umber “$144,000” is replaced with “$72,000.”

 

2.               COUNTERPARTS. This Amendment may be executed in counterparts and all such counterparts taken together shall be deemed to constitute one and the same instrument. If this Amendment is executed in counterparts, no signatory hereto will be bound until both parties named below have duly executed a counterpart of this Amendment.

 

3.               EFFECT OF AMENDMENT.  Except as specifically amended hereby, all other terms and conditions of the TSA remain in effect. To the extent that any of the terms in the TSA are inconsistent with the terms of this Amendment, the terms of this Amendment shall control.

 

IN WITNESS WHEREOF, the United Therapeutics and KTI, intending to be legally bound have executed this Amendment as of the date first set forth above by their respective duly authorized representatives.

 

	
Kurzweil   Technologies Inc.
    	
 
    	
United Therapeutics Corporation
    
	
 
    	
 
    	
 
    
	
/s/   Raymond Kurzweil
    	
 
    	
/s/ Martine Rothblatt
    
	
Raymond Kurzweil, CEO
    	
 
    	
Martine Rothblatt, CEO
QuickLinks
 -- Click here to rapidly navigate through this document











 



 
 

Exhibit 10.50    
    


         

  


February 22,
2008 


Edmund
L. Quatmann, Jr.

c/o iPCS, Inc.

1901 N. Roselle Road

Schaumburg, IL 60195 


Dear
Mr. Quatmann: 


        Reference
is made to the Employment Agreement, dated as of March 7, 2007 (the "Employment Agreement"), between you and iPCS Wireless, Inc. Capitalized terms used herein but
not defined herein shall have the meanings set forth in the Employment Agreement. 


        I
am pleased to inform you that the Compensation Committee of the Board of Directors took the following actions effective January 1, 2008: 



	•
	Changed
your title to "Senior Vice President, General Counsel and Secretary."



	•
	Increased
your Annual Base Salary to $250,000.



	•
	Increased
your Incentive Bonus under the Incentive Bonus Plan at the target level of performance to 50% of your Annual Base Salary.



	•
	Amended
and restated in their entirety clauses (a) and (b) of paragraph 1 of Exhibit A to the
Employment Agreement to read as follows: 





"(a)    a
lump sum payment equal to 150% of Executive's Annual Base Salary; 


(b)    continuation
of health benefits for Executive and Executive's qualified beneficiaries for the period beginning on the Termination Date and ending on the 18-month
anniversary of the Termination Date at a cost which is no greater than is charged to active employees of the Company and their dependents, which continuing health benefits shall be provided only if
Executive and Executive's qualified beneficiaries, as applicable, make a timely and proper election to be covered under COBRA;" 





        This
constitutes an amendment of your Employment Agreement. Please acknowledge this amendment by countersigning below. 



	

 	

 	

Very truly yours,
	

 	

 	
iPCS, Inc.
	

 	

 	

By:	

/s/ Timothy M. Yager

	 	 	Name:  Timothy M. Yager
	 	 	Title:    CEO and President
	

AGREED AND ACKNOWLEDGED

this 22nd day of February, 2008	

 	

 
	

By:	

/s/ Edmund L. Quatmann, Jr.
	

 	

 













QuickLinks



Exhibit 10.50
Exhibit 32 - Certification  Pursuant to Section 906 of the Sarbanes-Oxley Act of
             2002

In  connection  with the  filing  of the  Quarterly  Report on Form 10-Q for the
Quarter  Ended  September  30, 2003,  (the  "Report") by  Interchange  Financial
Services  Corporation  ("Registrant"),  each of the undersigned hereby certifies
that:

1.   The Report fully complies with the  requirements  of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934, as amended, and

2.   The information  contained in the Report fairly  presents,  in all material
     respects, the financial condition and results of operations of Registrant.

                                        /s/ Anthony S. Abbate
                                        ______________________________
                                        Anthony S. Abbate
                                        President and Chief Executive Officer

                                        /s/ Charles T. Field
                                        ______________________________
                                        Charles T. Field
                                        Senior Vice President and CFO
EXHIBIT 31.1


Certification of Principal Executive Officer


Pursuant to Section 302 of the Sarbanes Oxley Act of 2002





I, Randy Churchey, certify that:





1. I have reviewed this Amendment No. 2 on Annual Report on Form 10-K/A of Education Realty Trust, Inc.;





2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; and





3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.





Date:  April 1, 2013/s/ Randy ChurcheyRandy ChurcheyChief Executive Officer







---
Court of Appeals

of the State of Georgia

ATLANTA,____________________

The Court of Appeals hereby passes the following order:

A21E0034. GWINNETT COUNTY, GEORGIA v. KERIA NELSON et al.

Appellant Gwinnett County (the “County”) moved for summary judgment in

this underlying suit for damages following a traffic accident. The trial court denied

the County’s motion in an order dated February 11, 2021. The court, however, issued

a timely certificate of immediate review on February 19, 2021, and the County’s

application for interlocutory application was thus due on March 1, 2021.

On March 3, 2021, the County filed the instant emergency motion, explaining

that “[t]he first [m]otion was [ ] filed one day late on March 2, 2021,” but “[t]he

[m]otion was rejected by” this Court due to the County’s failure to conform with our

filing requirements.

The County essentially seeks permission to file an untimely application for

interlocutory review, arguing that we should reach the merits of its application which

is based on the threshold issue of sovereign immunity. Asthe County acknowledges,

however, it failed to file a timely application for interlocutory review within ten days

of the trial court’s issuance of the certificate of review.1 See OCGA § 5-6-34 (b). The

statutory requirements for interlocutory review are jurisdictional. See Waye v.

Continental Special Risks, Inc., 289 Ga. App. 82, 84 (656 SE2d 150) (2007)

(dismissing application for interlocutory review due to appellant’s failure to file

1 Under our rules, there are no extensions of time to file applications for

interlocutory review. See Court of Appeals Rule 30 (i). 

March 04, 2021
application within ten days of the trial court’s grant of the certificate of immediate

review). Accordingly, the County’s emergency motion is DENIED.

Court of Appeals of the State of Georgia

Clerk’s Office, Atlanta,____________________

I certify that the above is a true extract from

the minutes of the Court of Appeals of Georgia.

Witness my signature and the seal of said court

hereto affixed the day and year last above written.

, Clerk.

03/04/2021
II 

112TH CONGRESS 

2D SESSION S. 2715 

To extend the temporary suspension of duty on chloromethylbenzene. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on 

chloromethylbenzene. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CHLOROMETHYLBENZENE. 

4 (a) IN GENERAL.—Heading 9902.22.18 of the Har5 monized Tariff Schedule of the United States (relating to 

6 chloromethylbenzene) is amended by striking the date in 

7 the effective period column and inserting ‘‘12/31/2015’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 2715 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
II 

112TH CONGRESS 

2D SESSION S. 2994 

To extend the temporary suspension of duty on diaminodecane. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. MENENDEZ introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on 

diaminodecane. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DIAMINODECANE. 

4 (a) IN GENERAL.—Heading 9902.23.02 of the Har5 monized Tariff Schedule of the United States (relating to 

6 diaminodecane) is amended by striking the date in the ef7 fective period column and inserting ‘‘12/31/2015’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies with respect to goods entered, or 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 2994 IS

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS
#### SKF USA INC. and SKF Sverige AB, Plaintiffs-Appellees, v. UNITED STATES, Defendant-Appellant, and The Torrington Company (now known as Timken U.S. Corporation), Defendant-Appellee.

No. 01-1295.

United States Court of Appeals, Federal Circuit.

April 26, 2004.

Herbert C. Shelley, Principal Attorney, Steptoe *&*Johnson, Washington, DC, for Plaintiffs-Appellants.

Terence P. Stewart, Principal Attorney, Stewart and Stewart, Washington, DC, for Defendant.

Velta A. Melnbrencis, Principal Attorney, Washington, DC, for Defendant-Cross Appellant.

*ORDER*

Upon consideration of the United States’ unopposed motion to voluntarily dismiss its appeal, 01-1295,

IT IS ORDERED THAT:

(1) The stay of proceedings is lifted and the motion to dismiss is granted.

(2) All sides shall bear their own costs.
Statement Pursuant to Section 906 of Sarbanes-Oxley Act of 2002





The undersigned, Daniel Dror, CEO, President and Chairman of American International Holdings Corp., a Texas corporation, hereby makes the following certification as required by Section 906(a) of the Sarbanes-Oxley Act of 2002, with respect to the following of this report filed pursuant to Section 15(d) of the Securities Exchange Act of 1934: Annual Report of Form 10-K for the period ended December 31, 2013.





The undersigned certifies that the above annual report fully complies with the requirements of Section 15(d) of the Securities Exchange Act of 1934, and information contained in the above quarterly report fairly presents, in all respects, the financial condition of American International Holdings Corp. and results of its operations.



Date: April 15, 2014

Daniel Dror

Chairman

/s/ Daniel Dror
# C_2009042EN.01S00301.xml

| 20.2.2009 | EN | Official Journal of the European Union | C 42/s3 |
| --- | --- | --- | --- |

20.2.2009

EN

Official Journal of the European Union

C 42/s3

---

NOTE TO THE READER

NOTE TO THE READER

The institutions have decided no longer to quote in their texts the last amendment to cited acts.

Unless otherwise indicated, references to acts in the texts published here are to the version of those acts currently in force.

---
II 

112TH CONGRESS 

2D SESSION S. 2915 

To suspend temporarily the duty on certain cast-iron engine crankcases for 

marine propulsion engines. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. LEVIN introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on certain cast-iron engine 

crankcases for marine propulsion engines. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CERTAIN CAST-IRON ENGINE CRANKCASES 

4 FOR MARINE PROPULSION ENGINES. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 2915 IS

‘‘ 9902.01.00 Cast-iron engine crankcases 

for marine propulsion engines, each measuring more 

than 1.1 meters in length 

(provided for in subheading 

8409.99.92) ........................... Free No change No change On or before 

12/31/2015 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS
II 

112TH CONGRESS 

2D SESSION S. 2799 

To extend the temporary reduction of duty on rubber basketballs. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. KERRY (for himself and Mrs. MURRAY) introduced the following bill; 

which was read twice and referred to the Committee on Finance 

A BILL 

To extend the temporary reduction of duty on rubber 

basketballs. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. RUBBER BASKETBALLS. 

4 (a) IN GENERAL.—Heading 9902.13.09 of the Har5 monized Tariff Schedule of the United States (relating to 

6 rubber basketballs) is amended by striking the date in the 

7 effective period column and inserting ‘‘12/31/2015’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies with respect to goods entered, or 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2799 IS

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
II 

112TH CONGRESS 

2D SESSION S. 2978 

To extend the temporary suspension of duty on 9, 10-Anthracenedione, 2- 

(1,1-dimethylpropyl)- (CAS No. 32588–54–8) and 9,10-anthracenedione, 

2-(1,2-dimethylpropyl)-. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. MENENDEZ introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on 9, 10- 

Anthracenedione, 2-(1,1-dimethylpropyl)- (CAS No. 

32588–54–8) and 9,10-anthracenedione, 2-(1,2- 

dimethylpropyl)-. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 9, 10-ANTHRACENEDIONE, 2-(1,1- 

4 DIMETHYLPROPYL)- (CAS NO. 32588–54–8) AND 

5 9,10-ANTHRACENEDIONE, 2-(1,2- 

6 DIMETHYLPROPYL)-. 

7 (a) IN GENERAL.—Heading 9902.24.05 of the Har8 monized Tariff Schedule of the United States (relating to 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 2978 IS

1 9, 10-Anthracenedione, 2-(1,1-dimethylpropyl)- (CAS No. 

2 32588–54–8) and 9,10-anthracenedione, 2-(1,2- 

3 dimethylpropyl)-) is amended by striking the date in the 

4 effective period column and inserting ‘‘12/31/2015’’. 

5 (b) EFFECTIVE DATE.—The amendment made by 

6 subsection (a) applies with respect to goods entered, or 

7 withdrawn from warehouse for consumption, on or after 

8 the 15th day after the date of the enactment of this Act. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS